Masschusetts General Hospital is a clinical research site located in Cambridge, Massachusetts, United States 02138.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Masschusetts General Hospital has participated in 1 clinical trials.
Therapeutic areas: Attention Deficit Hyperactivity Disorder, Attention Deficit Disorders With Hyperactivity, Attention Deficit Hyperactivity Disorders.
Sponsors: New River Pharmaceuticals.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Masschusetts General Hospital has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Masschusetts General Hospital has 1 clinical trials on record. Their work covers Attention Deficit Hyperactivity Disorder, Attention Deficit Disorders With Hyperactivity, Attention Deficit Hyperactivity Disorders.
Masschusetts General Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.